News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Genzyme Corporation First Phase of Job Cuts Will Eliminate 392 Positions
November 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Genzyme Corp. said it implemented yesterday the first phase of a previously announced job cut program. The first phase will cut 392 positions, the company said in a regulatory filing.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
MORE ON THIS TOPIC
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Viatris Will Cut Up to 10% of Global Workforce Over 3 Years
February 26, 2026
·
58 min read
·
BioSpace Editorial Staff
Job Trends
10 Companies Hiring in San Francisco and South San Francisco
February 26, 2026
·
2 min read
·
Angela Gabriel
Job Trends
The Right Fit: Contract Work Finds Increasing Favor Among Employers, Professionals
February 26, 2026
·
6 min read
·
Angela Gabriel